The use of a combination therapy to treat Alzheimer's disease is disclosed herein. The disclosed combination therapy comprises administration of a therapeutically effective amount of a combination of one or more agents used for treatment of the herpes simplex virus, one or more agents used for reducing insulin resistance, one or more anti-inflammatory agents, one or more agents for treatment of atheromatous plaques, and one or more agents for treating impaired neurogenesis.
